Health Boards
Taro Pharmaceutical reported today that it has received approval from the U.S. Food and Drug Administration (“FDA”) for its New Drug Application Topicort® (desoximetasone) Topical Spray, 0.25%.
*Topicort® (desoximetasone) Topical Spray, 0.25% is a corticosteroid indicated for the treatment of plaque psoriasis in patients 18 years of age or older.
Source: NO LINKS ALLOWED
*Topicort is also available in 0.05% Cream, 0.25% Cream, 0.05% Gel, & 0.25% Ointment. It's active ingredient is Desoximetasone a topical corticosteroids.
*Topicort® (desoximetasone) Topical Spray, 0.25% is a corticosteroid indicated for the treatment of plaque psoriasis in patients 18 years of age or older.
Source: NO LINKS ALLOWED
*Topicort is also available in 0.05% Cream, 0.25% Cream, 0.05% Gel, & 0.25% Ointment. It's active ingredient is Desoximetasone a topical corticosteroids.